JET-GBS - Japanese Eculizumab Trial for GBS

PHASE2CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

May 31, 2016

Study Completion Date

October 31, 2016

Conditions
Gullain Barre Syndrome
Interventions
DRUG

Eculizumab

DRUG

Placebo

Trial Locations (13)

Unknown

Nagoya University Hospital, Nagoya

Hokkaido University Hospital, Sapporo

Kobe City Medical Center General Hospital, Kobe

Kitasato University Hospital, Sagamihara

Kindai University Hospital, Ōsaka-sayama

National Defence Medical College Hospital, Tokorozawa

Dokkyo Medical University Hospital, Mibu

Tokyo Medical and Dental University Hospital, Bunkyo-ku

Tokyo University Hospital, Bunkyo-ku

Keio University Hospital, Shinjuku-ku

Chiba University Hospital, Chiba

Kyushu University Hospital, Fukuoka

Tokushima University Hospital, Tokushima

All Listed Sponsors
collaborator

Japan Agency for Medical Research and Development

OTHER_GOV

lead

Chiba University

OTHER

NCT02493725 - JET-GBS - Japanese Eculizumab Trial for GBS | Biotech Hunter | Biotech Hunter